These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 7284255)
1. Treatment of psoriasis vulgaris: gentleness to the entire psoriatic skin and the use of low concentrations of anthralin. Brody I Br J Dermatol; 1981 Aug; 105 Suppl 20():109-10. PubMed ID: 7284255 [No Abstract] [Full Text] [Related]
2. A topical treatment program for psoriasis with low anthralin concentrations. Brody I; Johansson A J Cutan Pathol; 1977 Oct; 4(5):233-43. PubMed ID: 342554 [TBL] [Abstract][Full Text] [Related]
3. Detection of anthralin in skin during treatment. Juhlin L; Schroot B Acta Derm Venereol Suppl (Stockh); 1985; 120():27-9. PubMed ID: 3869415 [TBL] [Abstract][Full Text] [Related]
4. [Effect of coal tar on cignolin erythema--1 hour treatment of psoriasis with high-dose cignolin with and without tar]. Schauder S; Mahrle G Z Hautkr; 1985 Jun; 60(11):875-83. PubMed ID: 3160177 [TBL] [Abstract][Full Text] [Related]
5. Anthralin therapy for psoriasis. A new look at an old compound. Gorsulowsky DC; Voorhees JJ; Ellis CN Arch Dermatol; 1985 Dec; 121(12):1509-11. PubMed ID: 4062331 [No Abstract] [Full Text] [Related]
6. Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin. Lowe NJ; Ashton RE; Koudsi H; Verschoore M; Schaefer H J Am Acad Dermatol; 1984 Jan; 10(1):69-72. PubMed ID: 6693604 [TBL] [Abstract][Full Text] [Related]
7. Innovative use of anthralin. An overview of past, present and future developments. Farber EM; Nall L Br J Dermatol; 1981 Aug; 105 Suppl 20():111-4. PubMed ID: 7284256 [No Abstract] [Full Text] [Related]
8. Mast cell alterations in chronic psoriasis vulgaris: response to low-strength anthralin treatment. A transmission electron microscopic study. Brody I Ups J Med Sci; 1986; 91(1):1-16. PubMed ID: 3716018 [TBL] [Abstract][Full Text] [Related]
9. The influence of treatment of the paralesional skin with dithranol on healing in psoriasis. Stankler L; Dave VK Br J Dermatol; 1975 Jan; 92(1):57-61. PubMed ID: 1098687 [TBL] [Abstract][Full Text] [Related]
10. [Current state and prospects of the use of cygnoline in the treatment of psoriasis]. Ciesielska J Przegl Dermatol; 1985; 72(1):77-90. PubMed ID: 3892593 [No Abstract] [Full Text] [Related]
11. Dithranol for psoriasis. Whitefield M Lancet; 1979 Mar; 1(8117):666. PubMed ID: 85893 [No Abstract] [Full Text] [Related]
12. Effect of short-contact anthralin therapy on ultraviolet B irradiation of psoriasis. Boer J; Smeenk G J Am Acad Dermatol; 1986 Aug; 15(2 Pt 1):198-204. PubMed ID: 3745524 [TBL] [Abstract][Full Text] [Related]
13. [Topical treatment of psoriasis]. Suhonen R Duodecim; 1985; 101(11):1135-41. PubMed ID: 4017905 [No Abstract] [Full Text] [Related]
18. [Comparison of conventional external methods of therapy in psoriasis vulgaris]. Köstler E; Seebacher C Z Arztl Fortbild (Jena); 1980 Apr; 74(8):367-9. PubMed ID: 7415310 [No Abstract] [Full Text] [Related]
19. [Dynamics of regression of psoriatic changes under the effect of cygnoline in the light of ultrastructural studies. II. Psoriatic changes after treatment with cygnoline]. Szczeklik-Franek A; Rubisz-Brzezińska JA; Grzybek H Patol Pol; 1979; 30(1):43-8. PubMed ID: 503597 [No Abstract] [Full Text] [Related]
20. Ultrastructural changes in psoriatic epidermis following anthralin treatment. Wilborn WH; Montes LF J Cutan Pathol; 1974; 1(3):132-50. PubMed ID: 4377841 [No Abstract] [Full Text] [Related] [Next] [New Search]